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ABSTRACT OF THESIS 
 
 
 
 
EFFECTS OF CELLULAR HETEROGENEITY AND IMMUNE CELLS IN 
ANGIOTENSIN II-INFUSED HEMORRHAGED ASCENDING AORTAS 
 
 
A previous thoracic aortic aneurysm time course study from our laboratory 
determined that ascending aortic dilation was significantly increased by day 5, 
and reached a plateau by day 28 of angiotensin II (AngII) infusion. We also found 
that mice had hemorrhage localized to the ascending aortas by day 5 of AngII 
infusion. The purpose of these studies was to provide mechanistic insight into the 
development of AngII-induced ascending aortic hemorrhage. 
Male C57BL/6 mice fed normal diet were subcutaneously infused with 
either AngII (1000 ng/kg/min) or saline for 5 days. To examine cellular 
heterogeneity, hemorrhaged ascending aortas were collected and sectioned 
serially for histological staining and immunostaining. I was unable to identify an 
entry point for blood into the media of the aortic root and ascending aorta. 
However, I found intimal, medial dissection near the hemorrhaged regions that 
may potentially be contiguous with the blood. To investigate infiltration of immune 
cells during AngII infusion, immunohistochemistry of hemorrhaged ascending 
 
  
aortas was performed. The numbers of macrophages and neutrophils in AngII-
infused aortas were increased in both medial and adventitial areas when 
compared with saline-infused aortas. 
Therefore, infiltration of immune cells at the point of dissection is 
associated with aortic hemorrhage during AngII infusion.  
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Chapter One 
 
I. Thoracic Aortic Aneurysms 
Thoracic aortic aneurysm (TAA) is defined as a localized dilatation of at 
least a 50% increase compared to the normal aorta. Incidence of TAA is 5.6 to 
10.4 cases per 100,000 patient-years. The prevalence of TAA in the general 
population without hypertension is up to 4.2 %.1-3 TAAs are classified into four 
anatomic categories: ascending aortic, aortic arch, descending aortic, and 
thoracoabdominal aortic regions.4 Sixty percent of TAAs commonly develop in 
the ascending aorta,5 while forty percent of TAAs occur in descending aortic 
region. The increased prevalence of TAAs in the population is thought to be due 
to improve screening techniques. 
TAA is an asymptomatic pathology until rupture occurs, thereby causing 
devastating health consequences. In general, growth rate of isolated idiopathic or 
degenerative ascending aortic aneurysm will be about 0.1 cm/year.6 If the aorta 
is >5 cm at the time of diagnosis, the growth rate may be accelerated up to 0.1 to 
0.15 cm/year.7 Other than diagnosis and monitoring, the only treatment is 
surgery to repair advanced TAAs.  
Etiology 
TAA etiologies include degenerative processes, genetic mutations, 
infection, inflammation, trauma, and dissection.3, 4 The most common cause of 
TAA is a degenerative process associated with age. Genetic disorders involving 
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TAA include Marfan’s syndrome (fibrillin-1 mutation), type IV Ehlers-Danlos 
syndrome (type III collagen deficiency), Loeys-Dietz syndrome (TGF-β receptors 
1/2 mutations), bicuspid aortic valve disease, and familial non-syndromic TAA.  
Marfan’s syndrome is an inheritable, autosomal dominant disease caused 
by over 800 mutations in the fibrillin-1 (FBN-1) gene.4 FBN-1, a connective 
protein, is the major component of elastin microfibrils. Marfan’s syndrome affects 
about 1 in 5000 humans.4 Cystic medial degeneration in young patients 
commonly occurs in Marfan’s syndrome and less-commonly in Ehlers-Danlos 
syndrome. The mutations of FBN-1 result in a reduction and loss in structure of 
elastin in the aortic wall. In addition, defects in FBN-1 lead to increased 
transforming growth factor- β (TGF-β) signaling, and subsequently increased 
tissue degradation and weakening of the aortic wall8, 9 leading to aortic dilation. 
Ehlers-Danlos syndrome is prevalent in approximately 1 in 5000 humans.4 
Type IV Ehlers-Danlos results from a defect of type III collagen due to mutations 
in the COL3A1 gene. This disease is manifested by severe aortic aneurysm and 
dissection.4 These patients have remarkably impaired vascular and connective 
tissues with an extremely high risk of aortic rupture, and are therefore difficult to 
repair surgically.10  
Loeys-Dietz syndrome has mutations in TGF-β receptors 1 and 2. This 
disorder is phenotypically similar to Marfan’s syndrome. Patients with this 
disorder develop TAA, rupture, or dissection at a young age.11 
Bicuspid aortic valve (BAV) disease is an autosomal dominant inherited 
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disease with reduced penetrance and affects 1-2% of the general population. It is 
the most common congenital abnormality in adulthood.12 The relationship 
between BAV and aortic aneurysms is well established. The aortic valve and 
ascending aorta share the same embryonic origin; the neural crest.13 BAV 
patients also have aortic pathology similar to patients with Marfan’s syndrome. 
Aortic aneurysms associated with BAV may occur in up to 50% of cases and 
involve the aortic root through the arch.14 These aneurysms have medial 
degeneration, increases in matrix metalloproteinase activity and reduction of 
FBN-1 in the aortic wall.15   
Familial non-syndromic TAA is a term used for patients who have a family 
or personal history of aortic aneurysm with unknown etiology. Twenty percent of 
TAA patients will have a family member with a similar history.7 This disorder has 
mutations in ACTA2 (Alpha-actin-2), MYH11 (Myosin-11), or TGFBR2 
(transforming growth factor, beta receptor II) genes.16, 17 The defect of ACTA2 
reduces smooth muscle α2 actin, decreases numbers of smooth muscle cells 
(SMCs), and increases elastin fiber degradation.  
Syphilis was the most common cause of TAA before development of 
antibiotics. Spirochetes of syphilis infect the aortic media, causing obliterative 
arteritis of the vasa vasorum in the proximal ascending aorta. Degeneration of 
collagen and elastic tissues leads to dilatation of the aorta.5 
There are two common non-infective and inflammatory arteritises: 
Takayasu’s and giant cell arteritis. Takayasu’s arteritis is a chronic inflammatory 
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disease of unknown etiology. This disease occurs more often in women.18 The 
cause of this disease is obliterative luminal changes in aorta and other involved 
arteries, which arise from acute inflammation at an early stage. Giant-cell arteritis 
may affect the aorta even though this disease typically affects temporal or canial 
arteries.19 
Treatment and Management 
Most patients with TAA are asymptomatic. Diagnosis of TAA is usually 
found incidentally when imaging (chest X-ray, CT scan, MRI, or echocardiogram) 
is ordered for other indications. The only current therapy for patients with TAAs is 
surgery. 
Recently, Dr. Dietz’s group reported that angiotensin receptor blockers 
attenuated the growth of TAA in Marfan’s patients.20 Even though blood pressure 
of these patients was not changed, the dilation of TAA was significantly reduced. 
In addition, renal functions were also normal in all patients after 3 months of ARB 
treatment. 
Other studies have reported benefits of β-blockers21, 22 and statins23 in 
chronic aortic aneurysms, although several large population studies have also 
shown no effects of these inhibitors.24, 25 
Pathology 
All of the TAA etiologies cause medial degeneration through inflammation, 
degradation of extracellular matrix, and apoptosis of vascular SMCs.4 One 
possible mechanism of medial degeneration is accumulation of reactive oxygen 
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species (ROS) that activate matrix metalloproteinases (MMPs), thereby, 
degrading extracellular matrix in aorta.26, 27 TGF-β, increased in Marfan’s 
syndrome and other inherited diseases, has been associated with thickening of 
the aortic wall and fragmentation of elastin in the media.28 Pathways of medial 
degeneration, including ROS production and TGF-β signaling in the cells, are 
part of common inflammatory cascades. Thus, the complexity of signal 
transduction pathways including mitogen-activated protein kinase cascade has 
been implicated in formation of aortic aneurysms. 
Animal Models 
AngII is the main effective molecule in the renin-angiotensin system. AngII 
infusion leads to a variety of vascular diseases in different animal models 
including atherosclerosis and aneurysms.29, 30 Recent studies demonstrate that 
AngII infusion induces TAAs in C57BL/631 and hypercholesterolemic mice.32, 33 
These TAAs have similar pathological characteristics, including ascending aortic 
dilatation, medial thickening, and elastin destruction, when compared to the 
fibrillin-1 mutated mice, a Marfan’s syndrome model.34  
There are three main animal models of Marfan’s syndrome: FBN-1C1039G/+, 
FBN-1mg∆/mg∆, and mgR/mgR.34-36 A complete deficiency of fibrillin-1 in mice, 
FBN-1C1039G/C1039G has embryonic lethality. FBN-1mg∆/mg∆ mice are born with 10-
fold-less expression of FBN-1 and live for 9-18 weeks.35 Mice homozygous for 
the mgR mutation have a 5-fold reduction of FBN-1 expression and live about 27 
weeks.36 Thus, a commonly used animal model for Marfan’s syndrome is 
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heterozygous FBN-1C1039G/+.34 This heterozygous mouse is born with a normal 
phenotype and life span but may develop ascending aortic aneurysm after 2 
months.34  
Another genetically modified TAA animal model is fibulin-4 mutant mice. 
Fibulin-4-/- mice die perinatal due to aortic rupture,37 and fibulin-4R/R mice also 
start to die after birth due to reduction of fibulin-4 leading to aortic dissection.38 
Lastly, abluminal calcium chloride application on the descending aorta of 
129/SvE mice creates TAA formation. Mice have ascending aortic dilation but 
reduced medial thickness.39  
Renin Angiotensin System (RAS) in Vascular Pathology 
AngII is a major effector in the RAS. This octapeptide is formed from 
enzymatic cleavage of angiotensinogen to angiotensin I (AngI) by renin which is 
secreted from the kidney. Next, angiotensin converting enzyme (ACE) cleaves 
AngI between amino acid 8 (Phe) and 9 (His), converting it to AngII. 
 Increased concentrations of AngII lead to binding to the angiotensin type 1 
receptor (AT1R), resulting in activation of several signaling cascades, that 
regulate various physiological and pathological effects. AngII affects all vascular 
cells, including endothelial cells, SMCs, fibroblasts, and monocyte/macrophages. 
Thus, AngII is important to the development of vascular diseases. Changes in 
phenotype and morphology of these cells, as well variations in gene expression 
lead to vascular pathogenesis. 
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 Pathologic AngII-induced signaling in various cells, including immune cells, 
SMCs, and endothelial cells, promotes reactive oxygen species (ROS) 
generation, inflammation, migration, growth, platelet activation, and fibrosis. All of 
these effects generate and contribute to various vascular diseases, including 
atherosclerosis and abdominal aortic aneurysms. These vascular diseases may 
be attenuated by antagonism of AngII actions. Recent studies partially explained 
the benefits of angiotensin converting enzyme inhibitors and angiotensin II 
receptor blocker therapy.4, 28, 40, 41    
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Chapter Two 
 
1. Introduction 
 
Many studies have reported that AngII infusion leads to formation of 
abdominal aortic aneurysms. Recently, it has been observed that AngII infusion 
into mice also leads to aneurysms of the ascending aorta.32, 33 Ascending aortic 
aneurysms have distinctly different pathological characteristics to aneurysms 
formed in the abdominal aorta. For instance, abdominal aortic aneurysm is highly 
prevalent in aged males with smoking being a major risk factor;42, 43  whereas 
ascending aortic aneurysms frequently occur in young people and are more 
commonly associated with genetic disorders in connective tissues.44 During a 
study to determine sequential pathological changes in AngII-induced ascending 
aortic aneurysms, we noted that medial disruption including intralamellar 
hemorrhage (blood accumulation within lamellae), was a common occurrence 
within days of initiating AngII infusion. 
The ascending aorta is composed of smooth muscle cells (SMCs) from 
two different developmental origins: second heart field and cardiac neural crest.45 
SMCs mainly play a role in contraction, and maintain considerable plasticity 
based on their response to changes in local environmental information.46, 47 Thus, 
neural crest derived SMCs play a key instructive role in the complex 
morphogenesis of brachial arch-derived vessels. 
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Moreover, myofibroblasts were increased by consequences of tissue 
injury and promoted expression of several SMC differentiation markers. For 
instance, SM α-actin suppressed by SMCs under vascular injury was increased 
by adventitial myofibroblasts.48, 49   
Based on the above background, different origins of SMCs in the 
ascending aorta may be crucial in morphogenesis of TAAs. In addition, two 
different cell types in the ascending aorta, myofibroblasts and SMCs, may have 
opposite effects in vascular injury. These differences may play an important role 
in development of vascular diseases including aortic aneurysms. The purpose of 
this study was to examine the origin of intralamellar hemorrhage present in the 
ascending aorta during AngII infusion.  
 
2. Materials and Methods 
2.1. Mice and Diet 
C57BL/6J mice were purchased from The Jackson Laboratory (Cat# 0664; 
Bar Harbor, ME), and fed a normal laboratory diet (Harlan Teklad; Indianapolis, 
IN). All studies were performed with approval of the University of Kentucky 
Institutional Animal Care and Use Committee (IACUC). 
2.2. Drug Administration 
 Saline or AngII (Bachem; Cat# H-1706; Torrance, CA) was infused for 5 
days via subcutaneously implanted mini-osmotic pumps (Alzet Model#2001; 
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Durect Corp; Cupertino, CA) into 8-week-old male mice. Two groups of mice 
were studied: 1. vehicle (saline) , or 2. AngII (1,000 ng/kg/min) infusion. 
2.3. Pathology of ascending aortic dissection 
Blood was collected via cardiac puncture. Saline was perfused through the 
left ventricle of the heart until the aorta was completely cleared of blood. The 
aorta with attached heart was harvested. 
For cross sections: The aorta was cleaned and the heart was removed 
from the aorta. The lower three fours of heart was discarded and the upper 
portion of the heart was set apex down in a mold filled with Optimal Cutting 
Temperature (OCT) compound for frozen sectioning. Serial sections (10 μm) 
were acquired through the entire aortic root in sets of 10 slides with 9 sections 
per slide. 
For longitudinal sections: Vertical serial sections of the ascending aorta 
were collected on 10 consecutive slides with 6 sections on each slide.  
Immunostaining was performed on serial sections of the aortic root. Alpha-
actin (Abcam; Cat# ab5694) and reticular fibroblast (ER-TR7; Abcam; Cat# 
ab51824) antibodies were used for detecting SMCs and fibroblasts, respectively. 
Biotinylated goat anti-rabbit IgG (Vector; Cat# BA1000) and rabbit anti-rat IgG 
(Vector; Cat# BA4001) were used as secondary antibodies, respectively. 
Peroxidase-based ABC kits (Vector; Cat# PK6001) and the red chromogen, AEC 
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(Vector; Cat# SK4205), were used to detect the antigen-antibody reaction. Non-
immune IgGs (rabbit for α actin; rat for fibroblast) were used as negative controls. 
Histology: Serial sections were stained with Movat’s pentachrome (Cat# 
S2087; PolyScientific; Bay Shore, NY) and Hematoxylin & Eosin (H&E; Eosin; 
Sigma; Cat# E8761; St. Louis, MO).   
 
3. RESULTS 
3.1 The proximal edge of AngII-induced hemorrhage did not co-localize 
with the transition of smooth muscle phenotype in the ascending aorta 
To locate the source of blood in intralamellar hemorrhage of the ascending 
aorta, 8-week-old male C57BL/6J (N=20) were fed normal laboratory diet during 
5 days of AngII infusion. Hemorrhage was visible from the ascending aorta to the 
carotid branches of the aortic arch at day 5 of AngII infusion. The incidence of 
hemorrhage was 30% (6 out of 20).  
Ascending aortas were collected and sectioned serially. Sections were 
immunostained for detection of SMCs by an anti-α-actin antibody (Figure 2.1 A, 
D, G), and fibroblast cells by an anti-ERTR7 antibody (Figure 2.1 B, E, H). Elastin 
breaks were detected using Movat’s pentachrome staining (Figure 2.1 C, F, I). 
The sections in Figure 2.1 were located from the ascending aorta to aortic root 
and intervals between A, B, C and D,E,F, or from D, E, F to G, H, I were 400 μm 
or 300 μm, respectively.  
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The major medial cell type was fibroblasts not SMCs in aortic root sinuses. 
(Figure 2.1 G, H) Fibroblast cells gradually diminished from the aortic root to the 
ascending aorta and located predominately in the perivascular area, whereas 
SMCs gradually increased in the media. (Figure 2.1 A, B, D, E, G, H) Elastin 
layers were intact in the ascending aorta proximal to the aortic root. (Figure 2.1 
C, F, I) 
The proximal edge of the ascending aorta with hemorrhage was not 
present in these sections. Hemorrhage in the ascending aortas of mice infused 
with AngII did not reach the aortic root region. 
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Figure 2.1 The proximal edge of AngII-induced hemorrhage did not co-
localize with the transition of smooth muscle phenotype in the ascending 
aorta. Immunostaining for SMCs and fibroblasts, and histological staining using 
Movat’s pentachrome of cross-sections from the aortic root through the 
ascending aorta of an AngII-infused mouse. Serial sections A, B, C are the 
ascending aorta distal to the aortic root; serial sections D, E, F are 400 μm 
proximal from upper panels, and G, H, I are 300 μm proximal from the middle 
panels. Panels A, D, G are immunostained by anti-α-actin antibody for detecting 
SMCs, panel B, E, H by anti-ERTR7 antibody for fibroblast cells. Red color 
indicates positive cells. The right panels (C, F, I) were stained with Movat’s 
pentachrome to detect elastic fibers in media indicated by black color. 
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3.2 AngII infusion developed not only hemorrhage, but also medial breaks 
in the ascending region 
Aortic dissection was found in AngII-infused hemorrhaged aortas at 5 days 
of AngII infusion. Two out of 6 hemorrhaged aortas had medial breaks. Serial 
sections were cut through ascending aortas with hemorrhage. These sections 
were stained and examined for pathological characteristics. I detected a 
dissection in serial sections of the ascending aorta. The distal section of the 
aortic dissections nearest the aortic arch had two regions of intralamellar 
hemorrhage in the media. (Figure 2.2 A) The section of the ascending aorta in 
Figure 2.2 B was located in 400 μm distal to Figure 2.2 A. This aortic dissection 
was extensive and maximally dilated. The section in Figure 2.2 C was 300 μm 
distal to Figure 2.2 B.  
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Figure 2.2 AngII infusion developed both hemorrhage and dissection in the 
ascending region. Movat’s pentachrome staining of the hemorrhaged ascending 
aortas shows aortic dissection. (A) The ascending aorta near the aortic arch 
showed two hemorrhaged regions indicated by blue arrows. (B) This section was 
400 μm proximal to (A) and had large luminal dilation. (C) was 300 μm proximal 
to (B) and the dilation was attenuated. Red arrows indicate dissection in the 
aorta. 
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3.3 Hemorrhaged ascending aorta compromised medial dissection in the 
anterior wall 
Longitudinal serial sections of hemorrhaged aortas infused for 5 days with 
AngII may identify the origin of blood. For this study, we infused mice (N=20) with 
AngII and three hemorrhaged aortas were observed. These aortas were serially 
sectioned longitudinally and H&E staining was performed. In Figure 2.3, panel A 
shows vertical sections of a hemorrhaged aorta. Panels B, C, and D are 
magnified 200X to focus on specific parts of the hemorrhaged aorta. In panel B, 
the dissected region on the anterior aortic wall can be observed. The area of 
blood accumulation was detected using H&E staining. Several medial layers of 
disrupted elastin fibers can be seen in panel C. However, there were no medial 
elastin breaks visible in posterior regions of the aorta. (Figure 2.3 D) 
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Figure 2.3 Hemorrhage of the ascending aorta compromised medial 
dissection in the anterior wall H&E staining of a longitudinal section of the 
hemorrhaged ascending aorta detected accumulated blood (A). A magnified view 
of the compromised medial integrity on the anterior wall is shown in the blue inset 
(B). Elastin fragmentation was frequent in the anterior wall as shown in the yellow 
inset (C). Intact elastin layers in the posterior ascending aorta are shown in the 
green inset (D). Red arrows indicate areas of decreased medial integrity. 
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4. Conclusions 
As illustrated in Figure 2.1, the source of blood in AngII-infused 
hemorrhaged aortas was not located in the proximal region near the aortic sinus, 
which is the transition point between two origins, the second heart field and the 
cardiac neural crest. Although the source of thrombus is still unknown, I found 
that myofibroblasts are the major cell type in the aortic sinus, and different origins 
of SMCs, located in the media of the ascending aorta, were not directly 
implicated with the source of blood in intralamellar hemorrhage. 
Aortic dissection in cross-sections was found in AngII-infused 
hemorrhaged ascending aortas. Dissection may be the entry point of blood into 
the media of ascending aorta, but all of hemorrhaged aortas for 5-day-AngII 
infusion did not show dissection and the number of aortic dissections were few. 
In longitudinal aortic sections, hemorrhage in ascending aortas was located on 
the anterior region and had pathological characteristics of medial breaks and 
elastin degeneration. However, elastin degradation was not observed in the 
posterior region of ascending aortas without hemorrhage. 
In summary, the origin of blood in AngII-infused hemorrhaged aortas is yet 
unknown but dissection may be one possible candidate of blood source for 
forming the intralamellar hemorrhage. 
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Chapter Three 
1. Introduction 
Leukocytes and TAA: Numerous studies have demonstrated that AngII 
infusion increases the presence of immune cells including macrophages, 
lymphocytes, and neutrophils in the aorta.50, 51 Medial macrophage accumulation 
and MMPs secretion are related to fragmentation of elastin fibers. Published 
papers from our laboratory have demonstrated that the deficiency of monocyte-
colony stimulating factor, a growth factor to influence the proliferation and 
differentiation of macrophages, reduces monocyte numbers yet hematomas were 
present in thoracic aortas.52 C-C chemokine receptor type 2 (CCR2) deficiency 
attenuated TAA formation in apolipoprotein E-/- mice and also decreased 
macrophage accumulation in the ascending aorta.32 Therefore, these studies 
demonstrated increase in macrophage numbers in TAAs during AngII infusion. 
Recently, Kurihara and colleagues demonstrated that neutrophils initiate acute 
aortic dissection.51 However, they used a neutralizing anti-granulocyte receptor-1 
(Gr-1) antibody that recognizes not only neutrophils (Ly-6G) but also monocytes 
(Ly-6C) for neutrophil depletion.  
Monocytes/Macrophages: Monocytes are heterogeneous, circulating 
blood cells that rapidly extravasate into inflamed tissues. Many studies have 
determined that AngII infusion leads to macrophage accumulation in TAAs.31, 32 
Many published papers have determined that patients with TAAs have increased 
immune cells including macrophages in aortic tissue.51, 53 One possible role of 
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AngII could involve inflammatory responses, triggering the infiltration of immune 
cells into aortic tissue. Ruiz-Ortega and colleagues stated that AngII can induce 
infiltration of immune cells, especially monocytes during inflammation.54 
Neutrophils: Neutrophils are abundant immune cells in blood and are the 
first leukocyte recruited into sites of acute inflammatory injury. Their survival in 
inflammatory sites is increased as 3-4 times compared with their basal half life in 
circulation.55, 56  
Many studies have demonstrated that an anti-Ly-6G antibody is specific 
for neutrophils,57, 58 and neutrophils were increased in patients with acute aortic 
dissection and rupture.51, 59 
 
2. Material and Methods 
2.1. Mice and Diet 
Mice and diet were used from the same source in the previous chapter.  
2.2. Drug Administration 
Saline or AngII (Bachem; Cat# H-1706; Torrance, CA) was infused for 5 
days via subcutaneously implanted mini-osmotic pumps (Alzet Model#2001; 
Durect Corp; Cupertino, CA) into male mice at the age of 8 weeks. Two groups of 
mice were studied: 1. vehicle (saline) infusion (N=5), and 2. AngII 1,000 
ng/kg/min infusion (N=15). 
2.3. Pathology of ascending aortas 
 
21 
 
Pathological procedures were the same as discussed in the previous 
chapter.  
Immunostaining was performed on serial sections of the aortic root. Anti-
CD68 (AbDSerotec; Cat# MCA1957) and anti-Ly-6G (BD Pharmingen; Cat# 
551459) antibodies were used for detection of macrophages and neutrophils, 
respectively. Biotinylated goat anti-rabbit IgG (Vector; Cat# BA1000) and rabbit 
anti-Rat IgG (Vector; Cat# BA4001) were used as secondary antibodies, 
respectively. Peroxidase-based ABC kits (Vector; Cat# PK6001) and the red 
chromogen, AEC (Vector; Cat# SK4205), were used to detect antigen-antibody 
reactions. Non-immune IgG (rat for macrophages or neutrophils) were used as 
negative controls. 
Histology: Serial sections were stained with Movat’s pentachrome 
(PolyScientific; Cat# S2087; Bay Shore, NY) and H & E (Eosin; Sigma; Cat# 
E8761; St. Louis, MO).   
 
3. RESULTS 
3.1 Macrophages were abundant and surrounded the intralamellar 
hemorrhage of the ascending aorta 
Based on a laboratory defined measurement process of TAA, Jessica 
Moorleghen and Debra Rateri (staff in Dr. Alan Daugherty’s laboratory) 
measured lumen dilation of ascending aorta by ultrasonography. AngII infusion 
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into C57BL/6 mice rapidly increased luminal diameter on day 5, and lumen 
dilatation reached a plateau after day 5 through day 28. (Data not shown) 
Aortas were harvested on day 5 of AngII infusion. Collected aortas were 
serially sectioned as mentioned in the previous chapter. Serial sections of AngII-
infused hemorrhaged aortas were stained with H&E (Figure 3.1 A, B) or 
immunostained with an anti-CD68 antibody (Figure 3.1 C, D). Figure 3.1 shows a 
section of AngII-infused aorta showing dissection (red arrows). There is CD68 
positive staining around the dissection of the media and adventitia. (Figure 3.1 C, 
D)    
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                  H&E staining                                    Anti-CD68 Ab 
 
 
Figure 3.1 Macrophages were abundant and surrounded the intralamellar 
hemorrhage of the ascending aorta. H&E staining of the ascending aorta 
detected medial hemorrhage (blue arrows) and elastin breaks (red arrows) (A, 
B). CD68 positive cells stained red (C, D). 
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3.2 Macrophages were increased in ascending aortic aneurysm 
 Regions of aortic dissections without hemorrhage (Figure 3.2 A, B, C) and 
no dissection (Figure 3.2 D) in AngII-infused ascending aorta were stained by 
Movat’s pentachrome. From this staining, medial breaks were detected in Figure 
3.2 A, B, C, but not D. In addition, an abundance of macrophages were detected 
in the media and adventitia of the dissected region (Figure 3.2 E, F, G), but only 
in the adventitia of the non-dissected aortas (Figure 3.2 H). 
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                Movat’s pentachrome stain                 Anti-CD68 antibody 
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Figure 3.2 Macrophages accumulated at sites of elastin breaks. Cross 
sections of an ascending aorta infused with AngII. A-D represent histological 
staining using Movat’s pentachrome. Macrophages (red color) were detected by 
an anti-CD68 antibody (E-H).B-D and F-H were magnified from different color 
boxes in A and E. Red arrows represent the sites of elastin breaks. 
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3.3 Neutrophils detected in murine spleen using an Ly-6G antibody 
 Dr. Van Leeuwen and colleagues demonstrated that neutrophils (anti-Ly-
6G antibody) did not co-localize with macrophages (anti-CD68 antibody) in the 
merged immunofluorescent stain of murine spleen.60 I repeated the 
immunohistochemistry for the anti-Ly-6G antibody in murine spleen. In this study, 
I observed that the anti-Ly-6G antibody only detected cells in red pulp, but not 
white pulp in the spleen. (Figure 3.3 B) However, the anti-CD68 antibody stained 
in both red and white pulp. (Figure 3.3 A) Therefore, we confirmed that the anti-
Ly-6G antibody is specific for neutrophils because these antibodies have different 
staining patterns in spleen. 
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            Anti-CD68 antibody                       Anti-Ly-6G antibody 
 
 
Figure 3.3 Neutrophils detected in murine spleen using an anti-Ly-6G 
antibody. Immunostaining of macrophages (A) or neutrophils (B) in murine 
spleen. Macrophages were detected by an anti-CD68 antibody (A), neutrophils 
were detected by an anti-Ly-6G antibody (B). Red color represents positive cells. 
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3.4 Neutrophils were increased in both hemorrhaged and non-hemorrhaged 
ascending aortas 
After confirmation of the neutrophil antibody, I have immunostained aortas 
using anti-Ly-6G and anti-CD68 antibodies. (Figure 3.4) In A, C, E, macrophages 
were detected by anti-CD68 antibody and in B, D, F neutrophils were detected 
using the anti-Ly-6G antibody. Some macrophages were detected by anti-CD68 
antibody in saline-infused ascending aortas. (Figure 3.4 A) In addition, 
macrophages increased in the media and adventitia of AngII-infused aortas 
(Figure 3.4 C, E) compared to saline controls. Neutrophils were present in the 
adventitia of AngII-infused aortas (Figure 3.4 F) and the media and adventitia of 
hemorrhaged aortas (Figure 3.4 D). There were no Ly-6G positive cells detected 
in saline-infused aortas (Figure 3.4 B).  
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Figure 3.4 Neutrophils were increased in both hemorrhaged and non-
hemorrhaged ascending aortas. Immunostaining of macrophages or 
neutrophils in AngII-infused ascending aortas. Mice were infused by either saline 
(A, B) or AngII (C, D, E, F) for 5 days. AngII infusion for 5 days promoted 
intralamellar hemorrhage in the ascending aorta (E, F). Panels (A, C, E) were 
immunostained using an anti-CD68 antibody for detecting macrophages. Panels 
(B, D, F) were immunostained using an anti-Ly-6G antibody. Red color indicates 
positive cells. 
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4. Discussion 
Many studies have determined that macrophages were increased in both 
patient53 and animal models31, 32 of TAAs. My current study demonstrated that in 
the early stage of TAA formation, both macrophages and neutrophils 
accumulated. 
AngII promotes leukocyte infiltration during inflammation. These 
leukocytes may interplay to produce pro-inflammatory responses. Neutrophil 
infiltration is initiated by changes on the surface of endothelium that result from 
stimulation by inflammatory mediators.61 Endothelial cells can be directly 
activated by AngII based on the demonstration that endothelial AT1a receptor 
deficiency attenuates TAA formation.33 Neutrophils may promote TAA formation 
by inducing monocyte recruitment and activating macrophages during 
inflammation. This could be due to: 1) Granule proteins anchoring endothelial 
proteoglycan promoting monocyte rolling along the endothelium; 2) Neutrophil 
granule proteins activating endothelial cells and promoting cytokine and adhesion 
molecules by activated endothelium; 3) Neutrophil proteins secreted from 
recruited neutrophils in inflamed tissue activating formyl peptide receptors (FPR) 
and enabling the rapid recruitment of monocytes; 4) Neutrophils activating 
macrophages to process phagocytosis, promoting a “pro-resolution program”. 
During the “resolution program”, macrophages promote cytokines for anti-
inflammatory responses.61 These processes may explain interactions between 
neutrophils and macrophages in the media and adventitia of AngII-infused 
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aortas. 
 
5. Future studies 
Based on my studies and published literature, I hypothesize that AngII 
induced inflammation in the ascending aorta recruits neutrophils, which initiate 
early development of TAAs. (Figure 3.5) To examine this hypothesis, I would 
suggest two studies listed below. 
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Figure 3.5 A potential pathway: Neutrophils promote infiltration of 
macrophages during AngII-infused TAA formation. A potential pathway in 
which neutrophils play a role in promoting monocyte infiltration into aortic tissue 
of the ascending aorta. (A) AngII binds to angiotensin II type I receptors and 
activates endothelium to initiate neutrophil infiltration into the media and 
adventitia within 24 hours of infusion. (B) Based on the increase of neutrophil life 
span, this cell type will be present in maximum numbers in the media and 
adventitia by day 3 of AngII infusion. As neutrophils die, this promotes infiltration 
of macrophages into the media and adventitia. Apoptotic neutrophils are 
phagocytized by macrophages. (C) Within days through clearance of apoptotic 
neutrophils, the presence and infiltration of neutrophils decreases in the media 
and adventitia, while the number of macrophages increases.  
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Study 1: The signaling pathway of TAA formation is initiated when AngII 
binds to AT1a receptors. This triggers inflammatory responses in endothelial 
cells. AT1a receptors on endothelial cells, not leukocytes and SMCs, may be 
important for TAA formation based on evidence that AT1a receptor deficiency in 
endothelial cell attenuates AngII-induced TAAs.33 Endothelial cells activate 
adhesion molecules and cytokines to recruit leukocytes including neutrophils. In 
addition, neutrophils are increased in patients with acute aortic dissection,51 and 
my data also demonstrated that neutrophils were present at day 5 of AngII-
infusion in hemorrhaged ascending aortas. Moreover, macrophage accumulation 
by infiltrating monocytes is also important in the TAA formation, and infiltrated 
neutrophils may be responsible for the recruitment of macrophages into the 
ascending region during inflammation.61 To distinguish contributions of 
neutrophils, a time course study of 5 days will be performed because the plateau 
of luminal diameter dilation is reached at day 5. 
To determine whether infiltrating neutrophils mediate AngII-induced TAA 
formation, C57BL/6 mice will be infused with either saline or AngII, and will be 
analyzed for their responsiveness to AngII-infused TAA formation. 
Experimental groups: Eight week old, male C57BL/6 mice will be infused 
by either saline or AngII (1000 ng/kg/min) for day 0, 1, 2, 3, 4 and 5. I will use 10 
mice per group infused with AngII. Six mice infused with saline for each time 
point because I am expecting that there will be no TAAs formed in mice infused 
with saline.  
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 I will measure lumen dilation of ascending aorta by ultrasound at each 
time point. I will use a half of each group to detect neutrophils and macrophages. 
The remainder will be dissected with elastase and collagenase and immune cells 
will be collected using a 70 μm strainer. Numbers of neutrophils and 
macrophages will be measured using flow cytometry. 
 Study 2: Many studies have demonstrated that macrophages are 
detected in patients with TAAs. The findings from my studies demonstrated that 
AngII infusion augments the population of neutrophils and macrophages in the 
aortic medial and adventitia at an early time point in TAA formation. Neutrophils 
recruit macrophages during the pro-inflammatory response triggered by AngII 
infusion. Thus, I propose to determine the effect of neutrophil depletion, using a 
neutralizing anti-Ly-6G antibody, related to macrophage accumulation in the 
aortic media during early TAA formation. 
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